{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:31:27Z","timestamp":1794047487361,"version":"4.8.0"},"reference-count":54,"publisher":"Ferrata Storti Foundation (Haematologica)","issue":"12","license":[{"start":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T00:00:00Z","timestamp":1719446400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["haematol"],"abstract":"<jats:p>Chromosomal translocations in non-Hodgkin lymphoma (NHL) result in activation of oncogenes by placing them under the regulation of immunoglobulin heavy chain (IGH) super-enhancers. Aberrant expression of translocated oncogenes induced by enhancer activity can contribute to lymphomagenesis. The role of the IGH enhancers in normal B-cell development is well established, but knowledge regarding the precise mechanisms of their involvement in control of the translocated oncogenes is limited. The goal of this project was to define the critical regions in the IGH regulatory elements and identify enhancer RNA (eRNA). We designed a single guide RNA library densely covering the IGH enhancers and performed tiling CRISPR interference screens in three NHL cell lines. This revealed three regions crucial for NHL cell growth. With chromatin- enriched RNA sequencing we showed transcription from the core enhancer regions and subsequently validated expression of the eRNA in a panel of NHL cell lines and tissue samples. Inhibition of the essential IGH enhancer regions decreased expression of eRNA and translocated oncogenes in several NHL cell lines. The observed expression and growth patterns were consistent with the breakpoints in the IGH locus. Moreover, targeting the E\u03bc enhancer resulted in loss of B-cell receptor expression. In a Burkitt lymphoma cell line, MYC overexpression partially rescued the phenotype induced by IGH enhancer inhibition. Our results indicated the most critical regions in the IGH enhancers and provided new insights into the current understanding of the role of IGH enhancers in B-cell NHL. As such, this study forms a basis for development of potential therapeutic approaches.<\/jats:p>","DOI":"10.3324\/haematol.2023.284672","type":"journal-article","created":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T04:38:39Z","timestamp":1719463119000},"page":"4007-4020","source":"Crossref","is-referenced-by-count":4,"title":["Core regions in immunoglobulin heavy chain enhancers essential for survival of non-Hodgkin lymphoma cells are identified by a CRISPR interference screen"],"prefix":"10.3324","volume":"109","author":[{"given":"Marta El\u017cbieta","family":"Kasprzyk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weronika","family":"Sura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Podralska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Kazimierska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annika","family":"Seitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wojciech","family":"\u0141osiewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Wo\u017aniak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen E. J.","family":"Guikema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjan","family":"Diepstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joost","family":"Kluiver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anke","family":"Van den Berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Rozwadowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Dzikiewicz-Krawczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1856","published-online":{"date-parts":[[2024,6,27]]},"reference":[{"key":"69960","doi-asserted-by":"crossref","unstructured":"Thandra KC, Barsouk A, Saginala K, Padala SA, Barsouk A, Rawla P. Epidemiology of non-Hodgkin\u2019s lymphoma. Med Sci (Basel). 2021; 9(1):5.","DOI":"10.3390\/medsci9010005"},{"key":"69961","doi-asserted-by":"crossref","unstructured":"Sedeta E, Ilerhunmwuwa N, Wasifuddin M. Epidemiology of non-Hodgkin lymphoma: global patterns of incidence, mortality, and trends. Blood. 2022; 140(Supplement 1):5234-5235.","DOI":"10.1182\/blood-2022-158830"},{"key":"69962","doi-asserted-by":"crossref","unstructured":"K\u00fcppers R, Dalla-Favera R. Mechanisms of chromosomal translocations in B cell lymphomas. Oncogene. 2001; 20(40):5580-5594.","DOI":"10.1038\/sj.onc.1204640"},{"key":"69963","doi-asserted-by":"crossref","unstructured":"Ahmadi SE, Rahimi S, Zarandi B, Chegeni R, Safa M. MYC: a multipurpose oncogene with prognostic and therapeutic implications in blood malignancies. J Hematol Oncol. 2021; 14(1):121.","DOI":"10.1186\/s13045-021-01111-4"},{"key":"69964","doi-asserted-by":"crossref","unstructured":"Klanova M, Klener P. BCL-2 proteins in pathogenesis and therapy of B-cell non-Hodgkin lymphomas. Cancers (Basel). 2020; 12(4):938.","DOI":"10.3390\/cancers12040938"},{"key":"69965","doi-asserted-by":"crossref","unstructured":"Brassesco MS. Leukemia\/lymphoma-associated gene fusions in normal individuals. Genet Mol Res. 2008; 7(3):782-790.","DOI":"10.4238\/vol7-3gmr486"},{"key":"69966","doi-asserted-by":"crossref","unstructured":"Ferrad M, Ghazzaui N, Issaoui H, Cook-Moreau J, Denizot Y. Mouse models of c-myc deregulation driven by IgH locus enhancers as models of B-cell lymphomagenesis. Front Immunol. 2020; 11:1564.","DOI":"10.3389\/fimmu.2020.01564"},{"key":"69967","doi-asserted-by":"crossref","unstructured":"Saintamand A, Vincent-Fabert C, Marquet M. E\u03bc and 3\u2019RR IgH enhancers show hierarchic unilateral dependence in mature B-cells. Sci Rep. 2017; 7(1):442.","DOI":"10.1038\/s41598-017-00575-0"},{"key":"69968","doi-asserted-by":"crossref","unstructured":"Han Z, Li W. Enhancer RNA: what we know and what we can achieve. Cell Prolif. 2022; 55(4):e13202.","DOI":"10.1111\/cpr.13202"},{"key":"69969","doi-asserted-by":"crossref","unstructured":"P\u00e9ron S, Laffleur B, Denis-Lagache N. AID-driven deletion causes immunoglobulin heavy chain locus suicide recombination in B cells. Science. 2012; 336(6083):931-934.","DOI":"10.1126\/science.1218692"},{"key":"69970","doi-asserted-by":"crossref","unstructured":"Tan SH, Leong WZ, Ngoc PCT. The enhancer RNA ARIEL activates the oncogenic transcriptional program in T-cell acute lymphoblastic leukemia. Blood. 2019; 134(3):239-251.","DOI":"10.1182\/blood.2018874503"},{"key":"69971","doi-asserted-by":"crossref","unstructured":"Stasevich EM, Uvarova AN, Murashko MM. Enhancer RNA AL928768.3 from the IGH locus regulates MYC expression and controls the proliferation and chemoresistance of Burkitt lymphoma cells with IGH\/MYC translocation. Int J Mol Sci. 2022; 23(9):4624.","DOI":"10.3390\/ijms23094624"},{"key":"69972","doi-asserted-by":"crossref","unstructured":"Afshar R, Pierce S, Bolland DJ, Corcoran A, Oltz EM. Regulation of IgH gene assembly: role of the intronic enhancer and 5\u2019DQ52 region in targeting DHJH recombination. J Immunol. 2006; 176(4):2439-2447.","DOI":"10.4049\/jimmunol.176.4.2439"},{"key":"69973","doi-asserted-by":"crossref","unstructured":"Pinaud E, Marquet M, Fiancette R. The IgH locus 3\u2019 regulatory region: pulling the strings from behind. Adv Immunol. 2011; 110:27-70.","DOI":"10.1016\/B978-0-12-387663-8.00002-8"},{"key":"69974","doi-asserted-by":"crossref","unstructured":"Kasprzyk ME, Sura W, Dzikiewicz-Krawczyk A. Enhancing B-cell malignancies-on repurposing enhancer activity towards cancer. Cancers (Basel). 2021; 13(13):3270.","DOI":"10.3390\/cancers13133270"},{"key":"69975","doi-asserted-by":"crossref","unstructured":"Li K, Liu Y, Cao H. Interrogation of enhancer function by enhancer-targeting CRISPR epigenetic editing. Nat Commun. 2020; 11(1):485.","DOI":"10.1038\/s41467-020-14362-5"},{"key":"69976","doi-asserted-by":"crossref","unstructured":"Pajic A, Spitkovsky D, Christoph B. Cell cycle activation by c-myc in a Burkitt lymphoma model cell line. Int J Cancer. 2000; 87(6):787-793.","DOI":"10.1002\/1097-0215(20000915)87:6<787::AID-IJC4>3.0.CO;2-6"},{"key":"69977","doi-asserted-by":"crossref","unstructured":"Sanjana NE, Shalem O, Zhang F. Improved vectors and genome-wide libraries for CRISPR screening. Nat Methods. 2014; 11(8):783-784.","DOI":"10.1038\/nmeth.3047"},{"key":"69978","doi-asserted-by":"crossref","unstructured":"Afgan E, Baker D, van den Beek M. The Galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2016 update. Nucleic Acids Res. 2016; 44(W1):W3-W10.","DOI":"10.1093\/nar\/gkw343"},{"key":"69979","doi-asserted-by":"crossref","unstructured":"Freese NH, Norris DC, Loraine AE. Integrated genome browser: visual analytics platform for genomics. Bioinformatics. 2016; 32(14):2089-2095.","DOI":"10.1093\/bioinformatics\/btw069"},{"key":"69980","doi-asserted-by":"crossref","unstructured":"Kent WJ, Sugnet CW, Furey TS. The human genome browser at UCSC. Genome Res. 2002; 12(6):996-1006.","DOI":"10.1101\/gr.229102"},{"key":"69981","doi-asserted-by":"crossref","unstructured":"Basso K, Frascella E, Zanesco L, Rosolen A. Improved longdistance polymerase chain reaction for the detection of t(8;14) (q24;q32) in Burkitt\u2019s lymphomas. Am J Pathol. 1999; 155(5):1479-1485.","DOI":"10.1016\/S0002-9440(10)65463-6"},{"key":"69982","doi-asserted-by":"crossref","unstructured":"Chong LC, Ben-Neriah S, Slack GW. High-resolution architecture and partner genes of MYC rearrangements in lymphoma with DLBCL morphology. Blood Adv. 2018; 2(20):2755-2765.","DOI":"10.1182\/bloodadvances.2018023572"},{"key":"69983","doi-asserted-by":"crossref","unstructured":"Shiramizu B, Magrath I. Localization of breakpoints by polymerase chain reactions in Burkitt\u2019s lymphoma with 8;14 translocations. Blood. 1990; 75(9):1848-1852.","DOI":"10.1182\/blood.V75.9.1848.bloodjournal7591848"},{"key":"69984","doi-asserted-by":"crossref","unstructured":"Seda V, Mraz M. B-cell receptor signalling and its crosstalk with other pathways in normal and malignant cells. Eur J Haematol. 2015; 94(3):193-205.","DOI":"10.1111\/ejh.12427"},{"key":"69985","doi-asserted-by":"crossref","unstructured":"Ju Z, Volpi SA, Hassan R. Evidence for physical interaction between the immunoglobulin heavy chain variable region and the 3\u2019 regulatory region. J Biol Chem. 2007; 282(48):35169-35178.","DOI":"10.1074\/jbc.M705719200"},{"key":"69986","doi-asserted-by":"crossref","unstructured":"Ghazzaui N, Issaoui H, Ferrad M. E\u03bc and 3\u2019RR transcriptional enhancers of the IgH locus cooperate to promote c-myc-induced mature B-cell lymphomas. Blood Adv. 2020; 4(1):28-39.","DOI":"10.1182\/bloodadvances.2019000845"},{"key":"69987","doi-asserted-by":"crossref","unstructured":"Saintamand A, Saad F, Denizot Y 3\u2019RR targeting in lymphomagenesis. a promising strategy?. Cell Cycle. 2015; 14(6):789-790.","DOI":"10.1080\/15384101.2015.1010964"},{"key":"69988","doi-asserted-by":"crossref","unstructured":"Saad F, Saintamand A, Rouaud P, Denizot Y. Targeting the oncogene B lymphoma deregulator IgH 3\u2019 regulatory region does not impede the in vivo inflammatory response in mice. Oncoscience. 2014; 1(9):591-598.","DOI":"10.18632\/oncoscience.81"},{"key":"69989","doi-asserted-by":"crossref","unstructured":"Lu ZP, Ju ZL, Shi GY, Zhang JW, Sun J. Histone deacetylase inhibitor trichostatin A reduces anti-DNA autoantibody production and represses IgH gene transcription. Biochem Biophys Res Commun. 2005; 330(1):204-209.","DOI":"10.1016\/j.bbrc.2005.02.147"},{"key":"69990","doi-asserted-by":"crossref","unstructured":"Wourms MJ, Sulentic CE. The aryl hydrocarbon receptor regulates an essential transcriptional element in the immunoglobulin heavy chain gene. Cell Immunol. 2015; 295(1):60-66.","DOI":"10.1016\/j.cellimm.2015.02.012"},{"key":"69991","doi-asserted-by":"crossref","unstructured":"Kasprzyk ME, \u0141osiewski W, Podralska M, Kazimierska M, Sura W, Dzikiewicz-Krawczyk A. 7-[[(4-methyl-2-pyridinyl)amino] (2-pyridinyl)methyl]-8-quinolinol (compound 30666) inhibits enhancer activity and reduces B-cell lymphoma growth - a question of specificity. Eur J Pharmacol. 2021; 910:174505.","DOI":"10.1016\/j.ejphar.2021.174505"},{"key":"69992","doi-asserted-by":"crossref","unstructured":"Kovalchuk AL, Sakai T, Qi CF. 3\u2019Igh enhancers hs3b\/hs4 are dispensable for Myc deregulation in mouse plasmacytomas with T(12;15) translocations. Oncotarget. 2018; 9(77):34528-34542.","DOI":"10.18632\/oncotarget.26160"},{"key":"69993","doi-asserted-by":"crossref","unstructured":"Zimonjic DB, Keck-Waggoner C, Popescu NC. Novel genomic imbalances and chromosome translocations involving c-myc gene in Burkitt\u2019s lymphoma. Leukemia. 2001; 15(10):1582-1588.","DOI":"10.1038\/sj.leu.2402281"},{"key":"69994","doi-asserted-by":"crossref","unstructured":"Peng C, Eckhardt LA. Role of the Igh intronic enhancer E\u03bc in clonal selection at the pre-B to immature B cell transition. J Immunol. 2013; 191(8):4399-43411.","DOI":"10.4049\/jimmunol.1301858"},{"key":"69995","doi-asserted-by":"crossref","unstructured":"Marquet M, Garot A, Bender S. The E\u03bc enhancer region influences H chain expression and B cell fate without impacting IgVH repertoire and immune response in vivo. J Immunol. 2014; 193(3):1171-1183.","DOI":"10.4049\/jimmunol.1302868"},{"key":"69996","doi-asserted-by":"crossref","unstructured":"Saintamand A, Rouaud P, Garot A. The IgH 3\u2019 regulatory region governs \u03bc chain transcription in mature B lymphocytes and the B cell fate. Oncotarget. 2015; 6(7):4845-4852.","DOI":"10.18632\/oncotarget.3010"},{"key":"69997","doi-asserted-by":"crossref","unstructured":"Volpi SA, Verma-Gaur J, Hassan R. Germline deletion of Igh 3\u2019 regulatory region elements hs 5, 6, 7 (hs5-7) affects B cell-specific regulation, rearrangement, and insulation of the Igh locus. J Immunol. 2012; 188(6):2556-2566.","DOI":"10.4049\/jimmunol.1102763"},{"key":"69998","doi-asserted-by":"crossref","unstructured":"B\u00e9bin AG, Carrion C, Marquet M. In vivo redundant function of the 3\u2019 IgH regulatory element HS3b in the mouse. J Immunol. 2010; 184(7):3710-3717.","DOI":"10.4049\/jimmunol.0901978"},{"key":"69999","doi-asserted-by":"crossref","unstructured":"Manis JP, van der Stoep N, Tian M. Class switching in B cells lacking 3\u2019 immunoglobulin heavy chain enhancers. J Exp Med. 1998; 188(8):1421-1431.","DOI":"10.1084\/jem.188.8.1421"},{"key":"70000","doi-asserted-by":"crossref","unstructured":"Vincent-Fabert C, Truffinet V, Fiancette R, Cogn\u00e9 N, Cogn\u00e9 M, Denizot Y. Ig synthesis and class switching do not require the presence of the hs4 enhancer in the 3\u2019 IgH regulatory region. J Immunol. 2009; 182(11):6926-6932.","DOI":"10.4049\/jimmunol.0900214"},{"key":"70001","doi-asserted-by":"crossref","unstructured":"Garot A, Marquet M, Saintamand A. Sequential activation and distinct functions for distal and proximal modules within the IgH 3\u2019 regulatory region. Proc Natl Acad Sci U S A. 2016; 113(6):1618-1623.","DOI":"10.1073\/pnas.1514090113"},{"key":"70002","doi-asserted-by":"crossref","unstructured":"Pinaud E, Khamlichi AA, Le Morvan C. Localization of the 3\u2019 IgH locus elements that effect long-distance regulation of class switch recombination. Immunity. 2001; 15(2):187-199.","DOI":"10.1016\/S1074-7613(01)00181-9"},{"key":"70003","doi-asserted-by":"crossref","unstructured":"Vincent-Fabert C, Fiancette R, Pinaud E. Genomic deletion of the whole IgH 3\u2019 regulatory region (hs3a, hs1,2, hs3b, and hs4) dramatically affects class switch recombination and Ig secretion to all isotypes. Blood. 2010; 116(11):1895-1898.","DOI":"10.1182\/blood-2010-01-264689"},{"key":"70004","doi-asserted-by":"crossref","unstructured":"Le Noir S, Boyer F, Lecardeur S. Functional anatomy of the immunoglobulin heavy chain 3' super-enhancer needs not only core enhancer elements but also their unique DNA context. Nucleic Acids Res. 2017; 45(10):5829-5837.","DOI":"10.1093\/nar\/gkx203"},{"key":"70005","doi-asserted-by":"crossref","unstructured":"Morvan CL, Pinaud E, Decourt C, Cuvillier A, Cogn\u00e9 M. The immunoglobulin heavy-chain locus hs3b and hs4 3\u2019 enhancers are dispensable for VDJ assembly and somatic hypermutation. Blood. 2003; 102(4):1421-1427.","DOI":"10.1182\/blood-2002-12-3827"},{"key":"70006","doi-asserted-by":"crossref","unstructured":"Varano G, Raffel S, Sormani M. The B-cell receptor controls fitness of MYC-driven lymphoma cells via GSK3\u03b2 inhibition. Nature. 2017; 546(7657):302-306.","DOI":"10.1038\/nature22353"},{"key":"70007","doi-asserted-by":"crossref","unstructured":"Loddenkemper C, Anagnostopoulos I, Hummel M. Differential Emu enhancer activity and expression of BOB.1\/ OBF.1, Oct2, PU.1, and immunoglobulin in reactive B-cell populations, B-cell non-Hodgkin lymphomas, and Hodgkin lymphomas. J Pathol. 2004; 202(1):60-69.","DOI":"10.1002\/path.1485"},{"key":"70008","doi-asserted-by":"crossref","unstructured":"McCune RC, Syrbu SI, Vasef MA. Expression profiling of transcription factors Pax-5, Oct-1, Oct-2, BOB.1, and PU.1 in Hodgkin\u2019s and non-Hodgkin\u2019s lymphomas: a comparative study using high throughput tissue microarrays. Mod Pathol. 2006; 19(7):1010-1018.","DOI":"10.1038\/modpathol.3800622"},{"key":"70009","doi-asserted-by":"crossref","unstructured":"Sartorelli V, Lauberth SM. Enhancer RNAs are an important regulatory layer of the epigenome. Nat Struct Mol Biol. 2020; 27(6):521-528.","DOI":"10.1038\/s41594-020-0446-0"},{"key":"70010","doi-asserted-by":"crossref","unstructured":"Arnold PR, Wells AD, Li XC. Diversity and emerging roles of enhancer RNA in regulation of gene expression and cell fate. Front Cell Dev Biol. 2020; 7:377.","DOI":"10.3389\/fcell.2019.00377"},{"key":"70011","doi-asserted-by":"crossref","unstructured":"Pefanis E, Wang J, Rothschild G. RNA exosome-regulated long non-coding RNA transcription controls super-enhancer activity. Cell. 2015; 161(4):774-789.","DOI":"10.1016\/j.cell.2015.04.034"},{"key":"70012","doi-asserted-by":"crossref","unstructured":"Xiao S, Huang Q, Ren H, Yang M. The mechanism and function of super enhancer RNA. Genesis. 2021; 59(5-6):e23422.","DOI":"10.1002\/dvg.23422"},{"key":"70013","doi-asserted-by":"crossref","unstructured":"Dolloff NG. Discovery platform for inhibitors of IgH gene enhancer activity. Cancer Biol Ther. 2019; 20(4):571-581.","DOI":"10.1080\/15384047.2018.1538615"}],"container-title":["Haematologica"],"original-title":[],"link":[{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2023.284672\/77238","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2023.284672\/77837","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/11663\/77238","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:06:47Z","timestamp":1794046007000},"score":1,"resource":{"primary":{"URL":"https:\/\/haematologica.org\/article\/view\/haematol.2023.284672"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,27]]},"references-count":54,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2024,12,1]]}},"URL":"https:\/\/doi.org\/10.3324\/haematol.2023.284672","relation":{},"ISSN":["1592-8721","0390-6078"],"issn-type":[{"value":"1592-8721","type":"electronic"},{"value":"0390-6078","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6,27]]}}}